<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701008</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00102967</org_study_id>
    <nct_id>NCT04701008</nct_id>
  </id_info>
  <brief_title>Efficacy of Ketamine in Post Anesthesia Recovery Room</brief_title>
  <official_title>Observational Study of the Efficacy of Ketamine for Rescue Analgesia in the Post Anesthesia Recovery Room</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study to assess efficacy of IV ketamine bolus when used in the post anesthesia&#xD;
      recovery unit for uncontrolled pain despite use of opioids.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this observational study, the investigators will monitor all patients with significant&#xD;
      pain after any non-cardiac surgical intervention at the University of Alberta Hospital.&#xD;
&#xD;
      After receiving an adequate dose of potent opioids (hydromorphone, morphine), the&#xD;
      participants will receive up to 0,2-0,25 mg/kg IV ketamine bolus. In our center these boluses&#xD;
      are given with 10-20mg increments.&#xD;
&#xD;
      The adequate dose of opioids will be determined by the attending anesthesiologist, depending&#xD;
      on what patients received intraoperatively and on their comorbidities.&#xD;
&#xD;
      Pain scores will be assessed before and after administration of this drug. The incidence of&#xD;
      any side effect after ketamine administration will be documented.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in pain score after ketamine use in PACU</measure>
    <time_frame>in the immediate post-operative period in recovery room</time_frame>
    <description>The Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is what is used most often in our recovery room for pain assessment. A score of 0/10 means no pain, and 10/10 means worst pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects after ketamine use</measure>
    <time_frame>in the immediate post-operative period in recovery room</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Ketamine Adverse Reaction</condition>
  <condition>Pain, Refractory</condition>
  <condition>Pain, Intractable</condition>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Patients with significative post-operative pain despite</arm_group_label>
    <description>Patients with significant pain despite receiving narcotics in PACU will receive a bolus dose of IV ketamine to assess its efficacy for pain score reduction. Bolus doses are given by 10mg IV increments, to reach approximate dose of 0,25mg/kg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>IV ketamine - 10mg bolus may be repeated repeated 2-3 times depending on clinical judgement</description>
    <arm_group_label>Patients with significative post-operative pain despite</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The following patients will be identified and recruited at the post-anesthesia care unit:&#xD;
&#xD;
        Adult patients undergoing non-cardiac surgery at University of Alberta Hospital meeting the&#xD;
        following criteria:&#xD;
&#xD;
          1. age ≥ 18&#xD;
&#xD;
          2. significant pain despite narcotics used in post anesthesia care unit&#xD;
&#xD;
          3. ketamine ordered by attending anesthesiologist&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adult patients undergoing non cardiac surgery at University of Alberta Hospital meeting the&#xD;
        following criteria:&#xD;
&#xD;
          -  age ≥ 18&#xD;
&#xD;
          -  significant pain despite narcotics used in post-anesthesia care unit&#xD;
&#xD;
          -  ketamine ordered by attending anesthesiologist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal to receive ketamine&#xD;
&#xD;
          -  Patients undergoing cardiac surgery&#xD;
&#xD;
          -  Patients who received no narcotics&#xD;
&#xD;
          -  Contra-indication to receiving ketamine (determined by attending anesthesiologist)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Derek Dillane</last_name>
    <phone>(780) 407-8861</phone>
    <email>dillane@ualberta.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>t6g2b7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Dillane</last_name>
      <phone>(780) 407-8861</phone>
      <email>dillane@ualberta.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Brinck EC, Tiippana E, Heesen M, Bell RF, Straube S, Moore RA, Kontinen V. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018 Dec 20;12:CD012033. doi: 10.1002/14651858.CD012033.pub4.</citation>
    <PMID>30570761</PMID>
  </reference>
  <reference>
    <citation>Gillies A, Lindholm D, Angliss M, Orr A. The use of ketamine as rescue analgesia in the recovery room following morphine administration--a double-blind randomised controlled trial in postoperative patients. Anaesth Intensive Care. 2007 Apr;35(2):199-203.</citation>
    <PMID>17444308</PMID>
  </reference>
  <reference>
    <citation>Weinbroum AA. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth Analg. 2003 Mar;96(3):789-795. doi: 10.1213/01.ANE.0000048088.17761.B4.</citation>
    <PMID>12598264</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 5, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alberta</investigator_affiliation>
    <investigator_full_name>Derek Dillane</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>pain score reduction</keyword>
  <keyword>reduction in pain scores</keyword>
  <keyword>post-operative pain</keyword>
  <keyword>ketamine use in recovery room</keyword>
  <keyword>recovery room</keyword>
  <keyword>ketamine recovery</keyword>
  <keyword>ketamine rescue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Pain, Intractable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

